Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059810) titled 'Study on the Carry-over Effect of Vibegron Treatment in Women with Overactive Bladder' on April 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Sapporo Medical University
Condition:
Condition - Overactive bladder
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Among pharmacological treatments for overactive bladder (OAB), vibegron, a beta3-adrenoceptor agonist, has been reported to be associated with few adverse events and to...